The effect of hemolysis on several assays performed with the Hitachi 717 was quantified by relating the amount of error to the concentration of hemoglobin. Hemolysis interference was judged clinically significant when analyte concentration varied by >10% from the initial value. Hemolysis interference was significantfor alkaline phosphatase, aspartate aminotransferase, cr-amylase, bilirubin, creatine kinase, y-glutamyltransferase, lactate dehydrogenase, lactate dehydrogenase-1, potassium, and theophylline assays. Error (expressed in absolute terms) was linearly dependent on hemoglobin concentration and independent of the initial analyte concentration in each case, except for bilirubinand theophylline, where multiple regression analysis was required to quantify the effect. Relative error was dependent on the initial analyte concentration in all cases. Correction formulas were calculated from linear regression of absolute error vs hemoglobin concentration. Clinical application of correction formulas and mechanisms of hemolysis interference for each assay are discussed.
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Hemolysis
has long been recognized as a source of error in a variety of chemical analyses (1) (2) (3) (4) (5) (6) (7) (8) (9) . Major sources of error have been attributed to the release of erythrocyte contents, to spectral interference from hemoglobin, and to interference of hemoglobin or its derivatives with chemical reactions. 
Results
Hemolysis interference expressed as percent relative
error was found to be dependent on the concentrations of both analyte and hemoglobin in each case. An example is illustrated for a-amylase (PNP method) in Figure 1A . Note that 10% relative error occurs at widely different hemoglobin concentrations, according to the initial analyte concentration.
Because clinical significance could not be judged by relative error for more than one analyte concentration, we used absolute error instead.
Clinically significant negative hemolysis interference was found for the alkaline phosphatase assay, both a-amylase assays, and the y-glutamyltransferase assay.
Significant positive hemolysis interference was found for the assays of aspartate aminotransferase, creatine kinase, lactate dehydrogenase, lactate dehydrogenase-i, and potassium.
Variable interference was found for the bilirubin and theophylline assays.
We found that absolute error could be estimated by linear regression on the hemoglobin concentration (Figure 1B) for each analyte except bilirubin and theophylline (Figure 2 Figure 3 . al. (20) , who found no effect on the hemoglobin spectrum with AMP addition to hemolysate. If the rate of reaction between hemoglobin and AMP were constant, rate blanking could be used, in which the decrease in absorbance during the Ri reaction could be subtracted from the assay rate after the addition of R2. As Figure 4 demonstrates, the rate of AMP/hemolysate reaction differs, depending on the reagent source. A more pronounced biphasic reaction rate is seen with our source of A "two-test" or Rate-B assay is required to perform rate blanking on the Hitachi 717: the rate after Ri addition is subtracted from the rate after R2 addition, with each reagent addition defined as a separate test. Use of the "two-test" method requires that the Ri/interferent reaction rate is constant and remains so after R2 addition. The method also requires that R2 does not interact with the interferent.
In keeping with the temperature equilibration restrictions defined in Figure 3 , the measuring points for the rate-blanked assay were chosen as follows: for Ri, 4.8 -3.2 min; for R2, 10.0 -8.4 mm. The data in Table 4 demonstrate that rateblanking and mathematical correction both provide a good approximation of alkaline phosphatase activity in the presence of hemolysis.
The a-amylase (EPS) Ri reagent assay contains HEPES buffer, sodium chloride, magnesium chloride, and sodium aside. The Ria reagent tablet contains a-glucosidase and substrate. Figure 6 displays the interaction of hemolysate with HEPES, HEPES plus so- and Ri reagent with substrate (-.
-)
Final hemoglobinconcentration, 0.05 g/L; absorbance normalized to 3-mm readingsto account for temperaturestabilization dium aside, Ri reagent without substrate, and Ri reagent with substrate. When reaction curves for HEPES and HEPES plus aside are compared, at least part of the interferenceappears to be due to the interaction of sodium aside and hemoglobin. However, the same negative reaction rate is not observed in the curve for Ri, which also contains azide. The response for the interaction of hemolysate with Ri in the presence of substrate is biphasic. Therefore, rate blanking cannot be used for this assay to correct for hemolysis interference; moreover, there is a possible interaction of hemolysate with the substrate reagent. Table 4 .
sodium aside a negative reaction rate is seen. However, the Ri reagent displays no interaction with hemolysate, although aside is present in this reagent.
A negative reaction rate is seen for Ri with glycylglycine added. We attempted rate blanking with this assay, using the same measuring points as with the alkaline phosphatase assay. As Table 5 Because the interference is both dependent and independent of the analyte concentration, mathematical correction by multiple regression analysis (14) is necessary and provides an adequate prediction of hemolysis interference ( However, the factors we found agree well with those of investigators using similar methods (3, 6, 7, 23). in vitro hemolysis (24,   25) . However, the vast majority of hemolyzed samples in our laboratory are the product of in vitro processes. Of further concern is interindividual differences in intracellular analyte concentrations, which could produce variability in correction factor detennination.
This area also requires further investigation. 
